Corrigendum to: Die-Off Ratio Correlates with Increased TNF-α:IL-10 Ratio and Decreased IVF Success Rates Correctable with Humira (American Journal of Reproductive Immunology, (2012), 68, 5, (428-437), 10.1111/j.1600-0897.2012.01179.x);Die-Off Ratio Correlates with Increased TNF-α: IL-10 Ratio and Decreased IVF Success Rates Correctable with Humira

American Journal of Reproductive Immunology

Volumn 68, Issue 5, 2012, Pages 428-437

  Winger, Edward E ^a   Reed, Jane L ^a   Ashoush, Sherif ^b   El Toukhy, Tarek ^b   Taranissi, Mohamed ^b  

^a Laboratory for Reproductive Medicine and Immunology   (United States)

^b Assisted Reproduction and Gynaecology Centre   (United Kingdom)

Author keywords

Anti TNF therapy; Embryo quality; Endometriosis; Folliculogenesis; Implantation; Oocyte quality; TNF

Indexed keywords

ADALIMUMAB; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BIRTH RATE; CELL LEVEL; CLINICAL EFFECTIVENESS; EMBRYO TRANSFER; ENDOMETRIOSIS; FEMALE; FEMALE SUBFERTILITY; FERTILIZATION IN VITRO; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NIDATION; PREGNANCY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 84867476015     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.13161     Document Type: Erratum

References (30)

1. Gardner DK, Lane M, Watson AJ: A Laboratory Guide to the Mammalian Embryo. Oxford, UK, Oxford University Press, 2004.
2. Guerif F, Le Gouge A, Giraudeau B, Poindron J, Bidault R, Gasnier O, Royere D: Limited value of morphological assessment at days 1 and 2 to predict blastocyst development potential: a prospective study based on 4042 embryos. Hum Reprod 2007; 22:1973-1981.
3. Seli E, Bruce C, Botros L, Henson M, Roos P, Judge K, Hardarson T, Ahlström A, Harrison P, Henman M, Go K, Acevedo N, Siques J, Tucker M, Sakkas D: Receiver operating characteristic (ROC) analysis of day 5 morphology grading and metabolomic Viability Score on predicting implantation outcome. J Assist Reprod Genet 2011; 28:137-144.
4. Templeton A, Morris JK, Parslow W: Factors that affect outcome of in-vitro fertilisation treatment. Lancet 1996; 348:1402-1406.
5. Das M, Holzer HE: Recurrent implantation failure: gamete and embryo factors. Fertil Steril 2012; 97: 1021-1027.
6. Winger EE, Reed JL, Ashoush S, Ahuja S, El-Toukhy T, Taranissi M: Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF. Am J Reprod Immunol 2009; 61:113-120.
7. Winger EE, Reed JL, Ashoush S, El-Toukhy T, Ahuja S, Taranissi M: Birth Defect Rates in Women Using Adalimumab (Humira(®)) to Treat Immunologic-Based Infertility in IVF Patients. Am J Reprod Immunol 2011; 66:237-241.
8. Kwak-Kim JY, Chung-Bang HS, Ng SC, Ntrivalas EI, Mangubat CP, Beaman KD, Beer AE, Gilman-Sachs A: Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod 2003; 18:767-773.
9. Winger EE, Reed JL, Ashoush S, El-Toukhy T, Ahuja S, Taranissi M: Degree of TNF-α/IL-10 cytokine elevation correlates with IVF success rates in women undergoing treatment with Adalimumab (Humira) and IVIG. Am J Reprod Immunol 2011; 65:610-618.
10. Winger EE, Reed JL, Ashoush S, El-Toukhy T, Ahuja S, Taranissi M: Elevated Preconception CD56(+) 16(+) and/or Th1:Th2 Levels Predict Benefit from IVIG Therapy in Subfertile Women Undergoing IVF. Am J Reprod Immunol 2011; 66: 394-403. doi: 10.1111/j.1600-0897.2011.01018.x.
11. Carlberg M, Nejaty J, Fröysa B, Guan Y, Söder O, Bergqvist A: Elevated expression of tumour necrosis factor alpha in cultured granulosa cells from women with endometriosis. Hum Reprod 2000; 15:1250-1255.
12. Speyer BE, Pizzey AR, Ranieri M, Joshi R, Delhanty JD, Serhal P: Fall in implantation rates following ICSI with sperm with high DNA fragmentation. Hum Reprod 2010; 25:1609-1618.
13. Commenges-Ducos M, Tricaud S, Papaxanthos-Roche A, Dallay D, Horovitz J, Commenges D: Modelling of the probability of success of the stages of in-vitro fertilization and embryo transfer: stimulation, fertilization and implantation. Hum Reprod 1998; 13:78-83.
14. JOINT SOGC-CFAS: Guidelines for the number of embryos to transfer following in vitro fertilization No. 182, September 2006. Int J Gynaecol Obstet 2008; 102:203-216.
15. Vercammen MJ, Verloes A, Van de Velde H, Haentjens P: Accuracy of soluble human leukocyte antigen-G for predicting pregnancy among women undergoing infertility treatment: meta-analysis. Hum Reprod Update 2008; 14:209-218.
16. Austgulen R, Arntzen KJ, Vatten LJ, Kahn J, Sunde A: Detection of cytokines (interleukin-1, interleukin-6, transforming growth factor-beta) and soluble tumour necrosis factor receptors in embryo culture fluids during in-vitro fertilization. Hum Reprod 1995; 10:171-176.
17. Cianci A, Calogero AE, Palumbo MA, Burrello N, Ciotta L, Palumbo G, Bernardini R: Relationship between tumour necrosis factor alpha and sex steroid concentrations in the follicular fluid of women with immunological infertility. Hum Reprod 1996; 11:265-268.
18. Sarapik A, Velthut A, Haller-Kikkatalo K, Faure GC, Béné MC, de Carvalho Bittencourt M, Massin F, Uibo R, Salumets A: Follicular proinflammatory cytokines and chemokines as markers of IVF success. Clin Dev Immunol 2012; 2012:606459.
19. Morrison LJ, Marcinkiewicz JL: Tumor necrosis factor alpha enhances oocyte/follicle apoptosis in the neonatal rat ovary. Biol Reprod 2002; 66:450-457.
20. Wunder DM, Mueller MD, Birkhäuser MH, Bersinger NA: Increased ENA-78 in the follicular fluid of patients with endometriosis. Acta Obstet Gynecol Scand 2006; 85:336-342.
21. Falconer H, Sundqvist J, Gemzell-Danielsson K, von Schoultz B, D'Hooghe TM, Fried G: IVF outcome in women with endometriosis in relation to tumour necrosis factor and anti-Müllerian hormone. Reprod Biomed Online 2009; 18:582-588.
22. Revelli A, Delle Piane L, Casano S, Molinari E, Massobrio M, Rinaudo P: Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics. Reprod Biol Endocrinol 2009; 7: 40. Review.
23. Lian F, Li XL, Sun ZG, Zhang JW, Liu YH, Ma FM: Effect of Quyu Jiedu granule on microenvironment of ova in patients with endometriosis. Chin J Integr Med 2009; 15:42-46.
24. Wright HL, Bucknall RC, Moots RJ, Edwards SW: Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy. Rheumatology (Oxford) 2012; 51:451-459.
25. Gori I, Pellegrini C, Staedler D, Russell R, Jan C, Canny GO: Tumor necrosis factor-α activates estrogen signaling pathways in endometrial epithelial cells via estrogen receptor α. Mol Cell Endocrinol 2011; 345:27-37.
26. Gleicher N, Vidali A, Barad DH: Successful treatment of unresponsive thin endometrium. Fertil Steril 2011; 95:2123.
27. Cui LL, Yang G, Pan J, Zhang C: Tumor necrosis factor α knockout increases fertility of mice. Theriogenology 2011; 75:867-876.
28. Richter KS, Bugge KR, Bromer JG, Levy MJ: Relationship between endometrial thickness and embryo implantation, based on 1, 294 cycles of in vitro fertilization with transfer of two blastocyst-stage embryos. Fertil Steril 2007; 7:53-59.
29. Muasher SJ, Abdallah RT, Hubayter ZR: Optimal stimulation protocols for in vitro fertilization. Fertil Steril 2006; 86:267-273.
30. Swain JE: Optimizing the culture environment in the IVF laboratory: impact of pH and buffer capacity on gamete and embryo quality. Reprod Biomed Online 2010; 21:6-16.